1-1 of 1
Ariful Haque, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of Nilotinib, a Novel Tyrosine Kinase Inhibitor Administered to Imatinib-Resistant and -Intolerant Patients with Chronic Myelogenous Leukemia (CML) in Chronic Phase (CP).

Philipp le Coutre, MD, Kapil Bhalla, MD, Francis Giles, MD, Michele Baccarani, MD, Gert J. Ossenkoppele, MD, Andreas Hochhaus, MD, Norbert Gattermann, MD, Teresa Rafferty, MD, Ariful Haque, MD, Aaron Weitzman, MD, Hagop Kantarjian, MD
Journal: Blood
Blood (2006) 108 (11): 165.
https://doi.org/10.1182/blood.V108.11.165.165
Published: 2006